| 17alpha-ethynylestradiol | increases expression | ISO | RGD:1320340 | 6480464 | Ethinyl Estradiol results in increased expression of ANLN mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:1320340 | 6480464 | Ethinyl Estradiol affects the expression of ANLN mRNA | CTD | PMID:17555576 |
| 17beta-estradiol | increases expression | ISO | RGD:1320339 | 6480464 | Estradiol results in increased expression of ANLN mRNA | CTD | PMID:18310284 PMID:19167446 |
| 17beta-estradiol | increases expression | ISO | RGD:1320339 | 6480464 | Estradiol results in increased expression of ANLN mRNA | CTD | PMID:19167446 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1320340 | 6480464 | Tetrachlorodibenzodioxin affects the expression of ANLN mRNA | CTD | PMID:21570461 |
| 2-butoxyethanol | increases expression | ISO | RGD:1320340 | 6480464 | n-butoxyethanol results in increased expression of ANLN mRNA | CTD | PMID:19812364 |
| 2-methylcholine | affects expression | ISO | RGD:1320339 | 6480464 | beta-methylcholine affects the expression of ANLN mRNA | CTD | PMID:21179406 |
| 3-methylcholanthrene | increases expression | ISO | RGD:1320340 | 6480464 | Methylcholanthrene results in increased expression of ANLN mRNA | CTD | PMID:20713471 |
| 4,4'-diaminodiphenylmethane | affects expression | ISO | RGD:1320340 | 6480464 | 4,4'-diaminodiphenylmethane affects the expression of ANLN mRNA | CTD | PMID:18648102 |
| 4-hydroxynon-2-enal | decreases expression | ISO | RGD:1320340 | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of ANLN mRNA | CTD | PMID:19191707 |
| 5-fluorouracil | decreases expression | ISO | RGD:1320339 | 6480464 | Fluorouracil results in decreased expression of ANLN mRNA | CTD | PMID:17982676 |
| 5-fluorouracil | multiple interactions | ISO | RGD:1320339 | 6480464 | TP53 protein affects the reaction [Fluorouracil results in decreased expression of ANLN mRNA] | CTD | PMID:15016801 |
| 5-fluorouracil | multiple interactions | ISO | RGD:1320339 | 6480464 | TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of ANLN mRNA] | CTD | PMID:17982676 |
| acetohydrazide | decreases expression | ISO | RGD:1320340 | 6480464 | acetylhydrazine results in decreased expression of ANLN mRNA | CTD | PMID:15282401 |
| aflatoxin B1 | decreases expression | ISO | RGD:1320340 | 6480464 | Aflatoxin B1 results in decreased expression of ANLN mRNA | CTD | PMID:19770486 |
| aflatoxin B1 | affects expression | ISO | RGD:1320339 | 6480464 | Aflatoxin B1 affects the expression of ANLN protein | CTD | PMID:20106945 |
| benzene | decreases expression | ISO | RGD:1320339 | 6480464 | Benzene results in decreased expression of ANLN mRNA | CTD | PMID:21843810 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1320340 | 6480464 | Benzo(a)pyrene results in decreased expression of ANLN mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1320339 | 6480464 | Benzo(a)pyrene results in decreased expression of ANLN mRNA | CTD | PMID:20064835 PMID:21632981 |
| benzo[a]pyrene | increases expression | ISO | RGD:1320340 | 6480464 | Benzo(a)pyrene results in increased expression of ANLN mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1320339 | 6480464 | Benzo(a)pyrene results in decreased expression of ANLN mRNA | CTD | PMID:20064835 |
| calcitriol | decreases expression | ISO | RGD:1320339 | 6480464 | Calcitriol results in decreased expression of ANLN mRNA | CTD | PMID:21592394 |
| calcitriol | multiple interactions | ISO | RGD:1320339 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of ANLN mRNA | CTD | PMID:21592394 |
| cefaloridine | decreases expression | EXP | | 6480464 | Cephaloridine results in decreased expression of ANLN mRNA | CTD | PMID:18500788 |
| cisplatin | increases expression | ISO | RGD:1320340 | 6480464 | Cisplatin results in increased expression of ANLN mRNA | CTD | PMID:21151649 |
| cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of ANLN mRNA | CTD | PMID:22023808 |
| cobalt dichloride | decreases expression | ISO | RGD:1320339 | 6480464 | cobaltous chloride results in decreased expression of ANLN mRNA | CTD | PMID:19320972 |
| copper atom | multiple interactions | ISO | RGD:1320339 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of ANLN mRNA | CTD | PMID:20971185 |
| copper(0) | multiple interactions | ISO | RGD:1320339 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of ANLN mRNA | CTD | PMID:20971185 |
| copper(2+) sulfate | decreases expression | ISO | RGD:1320339 | 6480464 | Copper Sulfate results in decreased expression of ANLN mRNA | CTD | PMID:19549813 |
| coumestrol | multiple interactions | ISO | RGD:1320339 | 6480464 | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ANLN mRNA; more ... | CTD | PMID:19167446 |
| coumestrol | increases expression | ISO | RGD:1320339 | 6480464 | Coumestrol results in increased expression of ANLN mRNA | CTD | PMID:19167446 |
| coumestrol | multiple interactions | ISO | RGD:1320339 | 6480464 | [Coumestrol co-treated with ESR1 protein] results in increased expression of ANLN mRNA; more ... | CTD | PMID:18310284 |
| cyclosporin A | decreases expression | ISO | RGD:1320339 | 6480464 | Cyclosporine results in decreased expression of ANLN mRNA | CTD | PMID:20106945 |
| cyclosporin A | decreases expression | ISO | RGD:1320339 | 6480464 | Cyclosporine results in decreased expression of ANLN mRNA | CTD | PMID:19159671 more ... |
| dasatinib (anhydrous) | decreases expression | ISO | RGD:1320339 | 6480464 | dasatinib results in decreased expression of ANLN mRNA | CTD | PMID:20579391 |
| diethyl maleate | increases expression | EXP | | 6480464 | diethyl maleate results in increased expression of ANLN mRNA | CTD | PMID:21161181 |
| hydrogen peroxide | affects expression | ISO | RGD:1320339 | 6480464 | Hydrogen Peroxide affects the expression of ANLN mRNA | CTD | PMID:20044591 |
| lucanthone | decreases expression | ISO | RGD:1320339 | 6480464 | Lucanthone results in decreased expression of ANLN mRNA | CTD | PMID:21148553 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:1320340 | 6480464 | Diethylnitrosamine results in increased expression of ANLN mRNA | CTD | PMID:17854601 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of ANLN mRNA | CTD | PMID:19041683 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:1320340 | 6480464 | RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of ANLN mRNA] | CTD | PMID:17854601 |
| ozone | multiple interactions | ISO | RGD:1320340 | 6480464 | TTPA protein affects the reaction [Ozone results in increased expression of ANLN mRNA] | CTD | PMID:19555225 |
| paracetamol | increases expression | ISO | RGD:1320339 | 6480464 | Acetaminophen results in increased expression of ANLN mRNA | CTD | PMID:22230336 |
| phenobarbital | multiple interactions | ISO | RGD:1320340 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of ANLN mRNA] | CTD | PMID:19482888 |
| phenobarbital | increases expression | ISO | RGD:1320340 | 6480464 | Phenobarbital results in increased expression of ANLN mRNA | CTD | PMID:19482888 PMID:23091169 |
| phenobarbital | increases expression | ISO | RGD:1320340 | 6480464 | Phenobarbital results in increased expression of ANLN mRNA | CTD | PMID:19482888 |
| quercetin | decreases expression | ISO | RGD:1320339 | 6480464 | Quercetin results in decreased expression of ANLN mRNA | CTD | PMID:21632981 |
| resveratrol | decreases expression | ISO | RGD:1320339 | 6480464 | resveratrol results in decreased expression of ANLN mRNA | CTD | PMID:15767336 |
| resveratrol | multiple interactions | ISO | RGD:1320339 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of ANLN mRNA | CTD | PMID:19167446 |
| resveratrol | increases expression | ISO | RGD:1320339 | 6480464 | resveratrol results in increased expression of ANLN mRNA | CTD | PMID:19167446 |
| tamoxifen | affects expression | ISO | RGD:1320340 | 6480464 | Tamoxifen affects the expression of ANLN mRNA | CTD | PMID:17555576 |
| testosterone | multiple interactions | ISO | RGD:1320339 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of ANLN mRNA | CTD | PMID:21592394 |
| testosterone | decreases expression | ISO | RGD:1320339 | 6480464 | Testosterone results in decreased expression of ANLN mRNA | CTD | PMID:21592394 |
| tetrachloromethane | increases expression | ISO | RGD:1320340 | 6480464 | Carbon Tetrachloride results in increased expression of ANLN mRNA | CTD | PMID:17484886 |
| trans-resveratrol | decreases expression | ISO | RGD:1320339 | 6480464 | resveratrol results in decreased expression of ANLN mRNA | CTD | PMID:15767336 |
| trans-resveratrol | multiple interactions | ISO | RGD:1320339 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of ANLN mRNA | CTD | PMID:19167446 |
| trans-resveratrol | increases expression | ISO | RGD:1320339 | 6480464 | resveratrol results in increased expression of ANLN mRNA | CTD | PMID:19167446 |
| trimellitic anhydride | increases expression | ISO | RGD:1320340 | 6480464 | trimellitic anhydride results in increased expression of ANLN mRNA | CTD | PMID:19042947 |
| troglitazone | decreases expression | ISO | RGD:1320339 | 6480464 | troglitazone results in decreased expression of ANLN mRNA | CTD | PMID:19140230 |